ACAD - ACADIA PHARMACEUTICALS INC

QQQ $ 440.73 $ 0.67 (0.15 %)

DIA $ 392.80 $ 2.32 (0.59 %)

SPY $ 519.11 $ 1.92 (0.37 %)

TLT $ 90.47 $ 0.43 (0.48 %)

GLD $ 215.80 $ 1.10 (0.51 %)

Previous Close

$ 17.13

Open

$ 17.23

Bid

$ 15.54 x 600

Ask

$ 15.65 x 200

Day's Range

$ 15.39 - $ 17.30

52 Week Range

$ 16.16 - $ 33.99

Volume

2,140,858

Average Volume

Market Cap

2.85B

Beta (5Y Monthly)

$ 0.63

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-08-2024	03-31-2024	10-Q
2	02-28-2024	12-31-2023	10-K
3	11-02-2023	09-30-2023	10-Q
4	08-02-2023	06-30-2023	10-Q
5	05-08-2023	03-31-2023	10-Q
6	02-28-2023	12-31-2022	10-K
7	11-03-2022	09-30-2022	10-Q
8	08-08-2022	06-30-2022	10-Q
9	05-04-2022	03-31-2022	10-Q
10	03-01-2022	12-31-2021	10-K
11	11-08-2021	09-30-2021	10-Q
12	08-04-2021	06-30-2021	10-Q
13	05-06-2021	03-31-2021	10-Q
14	02-25-2021	12-31-2020	10-K
15	11-04-2020	09-30-2020	10-Q
16	08-06-2020	06-30-2020	10-Q
17	05-08-2020	03-31-2020	10-Q
18	02-27-2020	12-31-2019	10-K
19	10-31-2019	09-30-2019	10-Q
20	08-01-2019	06-30-2019	10-Q
21	05-02-2019	03-31-2019	10-Q
22	02-27-2019	12-31-2018	10-K
23	11-06-2018	09-30-2018	10-Q
24	08-08-2018	06-30-2018	10-Q
25	05-04-2018	03-31-2018	10-Q
26	02-27-2018	12-31-2017	10-K
27	11-07-2017	09-30-2017	10-Q
28	08-08-2017	06-30-2017	10-Q
29	05-09-2017	03-31-2017	10-Q
30	02-28-2017	12-31-2016	10-K
31	11-07-2016	09-30-2016	10-Q
32	08-04-2016	06-30-2016	10-Q
33	05-05-2016	03-31-2016	10-Q
34	02-29-2016	12-31-2015	10-K
35	11-05-2015	09-30-2015	10-Q
36	08-06-2015	06-30-2015	10-Q
37	05-07-2015	03-31-2015	10-Q
38	02-26-2015	12-31-2014	10-K
39	11-10-2014	09-30-2014	10-Q
40	08-05-2014	06-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Stifel Maintains Hold on ACADIA Pharmaceut...
05/09/2024 13:53:39

Stifel analyst Paul Matteis maintains ACADIA Pharmaceuticals (NASDAQ:ACAD) with a Hold and lowers the price target from $26 ...

Cantor Fitzgerald Reiterates Overweight on...
05/09/2024 13:51:53

Cantor Fitzgerald analyst Charles Duncan reiterates ACADIA Pharmaceuticals (NASDAQ:ACAD) with a Overweight and maintains $37...

Mizuho Maintains Neutral on ACADIA Pharmac...
05/09/2024 11:47:43

Mizuho analyst Uy Ear maintains ACADIA Pharmaceuticals (NASDAQ:ACAD) with a Neutral and lowers the price target from $25 to ...

Needham Reiterates Buy on ACADIA Pharmaceu...
05/09/2024 10:42:29

Needham analyst Ami Fadia reiterates ACADIA Pharmaceuticals (NASDAQ:ACAD) with a Buy and maintains $30 price target.

Baird Maintains Outperform on ACADIA Pharm...
05/09/2024 10:40:55

Baird analyst Joel Beatty maintains ACADIA Pharmaceuticals (NASDAQ:ACAD) with a Outperform and lowers the price target from ...

Acadia Reiterates 2024 Guidance
05/08/2024 20:43:14

Acadia is reiterating all of its 2024 guidance provided on February 27, 2024.DAYBUE net product sales guidance in the range of ...

ACADIA Pharmaceuticals Q1 2024 GAAP EPS $0...
05/08/2024 20:42:41

ACADIA Pharmaceuticals (NASDAQ:ACAD) reported quarterly earnings of $0.10 per share which missed the analyst consensus estimate...

Oppenheimer Maintains Perform on ACADIA Ph...
05/06/2024 11:44:32

Oppenheimer analyst Jay Olson maintains ACADIA Pharmaceuticals (NASDAQ:ACAD) with a Perform and maintains $19 price target.

ACADIA Pharmaceuticals Stock: A Deep Dive ...
04/30/2024 15:01:10

Cantor Fitzgerald Reiterates Overweight on...
04/30/2024 14:24:41

Cantor Fitzgerald analyst Charles Duncan reiterates ACADIA Pharmaceuticals (NASDAQ:ACAD) with a Overweight and maintains $37...

Acadia Pharmaceuticals Announces Trofineti...
04/22/2024 13:06:13

Acadia Pharmaceuticals Presents New DAYBUE...
04/17/2024 20:19:12

Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) today announced that two oral presentations featuring DAYBUE™ (trofinetide) findings ...

Cracking The Code: Understanding Analyst R...
04/10/2024 20:01:19

Cantor Fitzgerald Reiterates Overweight on...
04/10/2024 13:33:48

Cantor Fitzgerald analyst Charles Duncan reiterates ACADIA Pharmaceuticals (NASDAQ:ACAD) with a Overweight and maintains $37...

Needham Reiterates Buy on ACADIA Pharmaceu...
04/09/2024 10:28:23

Needham analyst Ami Fadia reiterates ACADIA Pharmaceuticals (NASDAQ:ACAD) with a Buy and maintains $32 price target.

Expert Ratings For ACADIA Pharmaceuticals
03/25/2024 14:00:54

JP Morgan Maintains Overweight on ACADIA P...
03/25/2024 13:19:51

JP Morgan analyst Tessa Romero maintains ACADIA Pharmaceuticals (NASDAQ:ACAD) with a Overweight and lowers the price target ...

10-health-care-stocks-with-whale-alerts-in-todays-session

10 Health Care Stocks With Whale Alerts In...
03/19/2024 17:35:23

Morgan Stanley Maintains Overweight on ACA...
03/13/2024 16:02:51

Morgan Stanley analyst Jeffrey Hung maintains ACADIA Pharmaceuticals (NASDAQ:ACAD) with a Overweight and lowers the price ta...

Why Asana Shares Are Trading Lower By 11%?...
03/12/2024 18:07:31

Shares of Asana, Inc. (NYSE: ASAN) fell sharply during Tuesday’s session following soft FY25 revenue guidance.